300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Retail
Oil and Gas
Social Impact
SaaS
Cryptocurrency
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Social Network
Facebook
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Hospitality
Biotechnology
Consumer
Sports
Legal
Software
Renewable Energy
eSports
Construction
Crowdfunding
Venture Capital
Theatre
Medical
Fashion
Recruiting
Social
Web3
Beauty
Cannabis
Infrastructure
LGBT
Mobile Apps
Celebrity
Life Science
Climate
Wine and Spirits
Music
Art
Real Estate
Food and Beverage
Sporting Goods
Manufacturing
Publishing
Digital Media
FinTech
Finance
Financial Services
Franchise
Mobile Advertising
Non Profit
Social Media
Internet
Sustainability
Android
Enterprise
Community
Media (Entertainment)
Hardware
Biotech
Impact
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Canada
Germany
India
United Kingdom
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Spain
Albania
Argentina
Bangladesh
Angola
Europe
Belgium
Cyprus
Barbados
Jordan
Austria
Qatar
Ethiopia
Azerbaijan
Bahamas
Bulgaria
Ecuador
Bolivia
Algeria
Faroe Islands
Estonia
Belize
Finland
Jersey
Bahrain
Italy
Belarus
Grenada
Hungary
Israel
Iceland
Liechtenstein
Lebanon
Cambodia
Honduras
Lithuania
Mongolia
Peru
Slovenia
San Marino
Vietnam
Ukraine
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
European Innovation Council, VC Fund

European Innovation Council

VC Fund

Brussels, Belgium

European Innovation Council is a VC fund in Brussels focused on Health Care and Biotechnology. The European Innovation Council aims to support top-class innovators, entrepreneurs, small companies, and researchers with bright ideas. The EIC co-invests alongside private investors in early-stage startups that have ESG impacts.

Total investments:
122
Last investment:
Lead investor:
54%

Last updated:

Industries European Innovation Council invests in

Health CareBiotechnologyMedical DeviceMedicalSoftware

Stages European Innovation Council invests in

GrantSeries APre-SeedVenture - Series UnknownSeries B

Countries European Innovation Council invests in

The NetherlandsGermanyFranceSpainIsrael

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Health Care 27 (22%)
  • Biotechnology 24 (20%)
  • Medical Device 21 (17%)
  • Medical 14 (11%)
  • Software 11 (9%)
See all 104 industries →

Stage

  • Grant 37 (30%)
  • Series A 20 (16%)
  • Pre-Seed 16 (13%)
  • Venture - Series Unknown 15 (12%)
  • Series B 12 (10%)
See all 10 stages →

Country

  • The Netherlands 18 (15%)
  • Germany 12 (10%)
  • France 10 (8%)
  • Spain 8 (7%)
  • Israel 8 (7%)
See all 27 countries →

Team

NameTitleInvestmentsLinksEmail
Ana Barjasic
Ana Barjasic Board Member
Board Member Total investments: 0 Find email
Andreas Lindblom
Andreas Lindblom EBAN Health Steering Committee
EBAN Health Steering Committee Total investments: 13
Find email
Barry Downes
Barry Downes Expert / Evaluator - European Innovation Council (EIC) Accelerator
Expert / Evaluator - European Innovation Council (EIC) Accelerator Total investments: 19
Find email
Brigitte Baumann
Brigitte Baumann President Emeritus
President Emeritus Total investments: 30
Find email
Candace Johnson
Candace Johnson President
President Total investments: 1
Find email
See all 20 team members →

Investments

CompanyDescriptionRoundLinks
Scandinavian Real Hearts Scandinavian Real Hearts
Scandinavian Real Hearts is a medical technology company that develops an artificial heart that will save the lives of hard-hearted people in transplant queue.The Scandinavian Real Hearts Total Artificial Heart (TAH) is created to be the closest copy of both the normal normal pumping, normal pressure ratio, and the normal pulse. Scandinavian RealHeart develops a Total Artificial Heart, with better function than those on the market, and can primarily be used as a transitional solution for patients who are waiting for a heart transplant. $715.1K / Post-IPO Equity / Jul 07, 2025
BrainEver BrainEver
BrainEver’s innovative therapeutic strategy is a translation of the work by Alain Prochiantz and colleagues on brain development and physiology. They demonstrated that homeoproteins, first identified as early developmental regulators, are also active throughout life and control several neuronal functions, including metabolism and epigeneticstability.BrainEver makes the hypothesis that, in patients, homeoprotein administration could durably modify the physiological resistance of surviving neurons while increasing their activity, thus leading to the improvement of clinical symptoms.Different homeoproteins that could be important in different neurodegenerative pathologies are being explored, the most advanced being Engrailed 1 (BREN01) for the treatment of Parkinson Disease and Amyotrophic Lateral Sclerosis (ALS).Beside Engrailed 1 in Parkinson Disease and ALS, BrainEver is currently generating a pipeline of 4 drug candidates targeting other neurodegenerative disease like Huntington Disease and Optic Neuropathies. $38.8M / Series B / Jul 03, 2025
H2SITE H2SITE
Systems and Membranes for high efficiency and purity Hydrogen production i.e. for Separation or Ammonia cracking Grant / Jul 03, 2025
RheEnergise RheEnergise
RheEnergise is bringing innovation to pumped hydro storage with High-Density Hydro®. Our mission is to create the technology that will allow for ultra-scalable long duration energy storage projects. High-Density Hydro is based on conventional pumped hydro, but utilises a high-density fluid instead of water, meaning that projects can be 2.5x smallerfor the same power. RheEnergise’s HD Hydro will be the lowest cost energy storage solution available, offering the greatest flexibility to the power grid. $2.9M / Grant / Jul 02, 2025
Groove Quantum Groove Quantum
Groove Quantum is a company that develops germanium-based quantum computing technology. $3M / Grant / Jul 01, 2025
Groove Quantum Groove Quantum
Groove Quantum is a company that develops germanium-based quantum computing technology. Jul 01, 2025
CroíValve CroíValve
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation $3M / Grant / Jul 01, 2025
Escala Medical Escala Medical
Escala Medical is developing the first minimally invasive, medical device for the treatment of women with pelvic organ prolapse (POP).Escala develops the first real nonsurgical, incision-free and mesh-free, repair device for the treatment of POP.Our system presents a long-overdue repair option for POP: it is safe and quick and preserves organfunctionality with minimal patient discomfort. As no incisions are required the procedure can be performed in an outpatient and office-based settings. Jun 30, 2025
Ever Dye Ever Dye
Ever Dye innovates in the fashion industry by developing ecological dyeing processes for the textile industry. $17.5M / Series A / Jun 25, 2025
Axiles Bionics Axiles Bionics
Axiles Bionics is a Brussels based spin-off from Brubotics (VUB – Free University Brussels), striving to improve the quality of life of people with assistive robotics. Our first focus today is with amputees and bringing the next generation bionic feet to the market. $7M / Series A / Jun 24, 2025
See all 122 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Retail
Oil and Gas
Social Impact
SaaS
Cryptocurrency
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Social Network
Facebook
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Hospitality
Biotechnology
Consumer
Sports
Legal
Software
Renewable Energy
eSports
Construction
Crowdfunding
Venture Capital
Theatre
Medical
Fashion
Recruiting
Social
Web3
Beauty
Cannabis
Infrastructure
LGBT
Mobile Apps
Celebrity
Life Science
Climate
Wine and Spirits
Music
Art
Real Estate
Food and Beverage
Sporting Goods
Manufacturing
Publishing
Digital Media
FinTech
Finance
Financial Services
Franchise
Mobile Advertising
Non Profit
Social Media
Internet
Sustainability
Android
Enterprise
Community
Media (Entertainment)
Hardware
Biotech
Impact
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Canada
Germany
India
United Kingdom
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Spain
Albania
Argentina
Bangladesh
Angola
Europe
Belgium
Cyprus
Barbados
Jordan
Austria
Qatar
Ethiopia
Azerbaijan
Bahamas
Bulgaria
Ecuador
Bolivia
Algeria
Faroe Islands
Estonia
Belize
Finland
Jersey
Bahrain
Italy
Belarus
Grenada
Hungary
Israel
Iceland
Liechtenstein
Lebanon
Cambodia
Honduras
Lithuania
Mongolia
Peru
Slovenia
San Marino
Vietnam
Ukraine
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does European Innovation Council invest in?

European Innovation Council invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Grant and Series A stage. Most of the 122 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact European Innovation Council?

Public channels for European Innovation Council include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at European Innovation Council?

The team at European Innovation Council includes Ana Barjasic (Board Member), Andreas Lindblom (EBAN Health Steering Committee) and Barry Downes (Expert / Evaluator - European Innovation Council (EIC) Accelerator), among 20 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
European Innovation Council European Innovation Council Find emails